These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37485727)

  • 81. Penehyclidine hydrochloride on postoperatively cognitive function.
    Hongyu X; Qingting W; Xiaoling S; Liwu Z; Ailing Y; Xin L
    Med Hypotheses; 2019 Aug; 129():109246. PubMed ID: 31371081
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Cholinesterase inhibitor treatment in patients with delirium.
    de Pont AC; van Geer MA; Schultz MJ
    Lancet; 2011 Mar; 377(9769):899; author reply 901. PubMed ID: 21397757
    [No Abstract]   [Full Text] [Related]  

  • 83. Rivastigmine for the treatment of anticholinergic delirium following severe procyclidine intoxication.
    Van Kernebeek MW; Ghesquiere M; Vanderbruggen N; Verhoeven E; Hubloue I; Crunelle CL
    Clin Toxicol (Phila); 2021 May; 59(5):447-448. PubMed ID: 32960128
    [No Abstract]   [Full Text] [Related]  

  • 84. IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease.
    Winblad B; Grossberg G; Frölich L; Farlow M; Zechner S; Nagel J; Lane R
    Neurology; 2007 Jul; 69(4 Suppl 1):S14-22. PubMed ID: 17646619
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Rivastigmine Use in the Treatment of Antimuscarinic Delirium.
    Greene SC
    J Med Toxicol; 2023 Jul; 19(3):284-287. PubMed ID: 37204613
    [No Abstract]   [Full Text] [Related]  

  • 86. Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson's disease.
    Dujardin K; Devos D; Duhem S; Destée A; Marié RM; Durif F; Lacomblez L; Touchon J; Pollak P; Péré JJ
    J Neurol; 2006 Sep; 253(9):1154-9. PubMed ID: 16998649
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Successful treatment of three elderly patients suffering from prolonged delirium using the cholinesterase inhibitor rivastigmine].
    van den Bliek BM; Maas HA
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2149; author reply 2149. PubMed ID: 15553363
    [No Abstract]   [Full Text] [Related]  

  • 88. Risk of pneumonia in new users of cholinesterase inhibitors for dementia.
    Lai EC; Wong MB; Iwata I; Zhang Y; Hsieh CY; Kao Yang YH; Setoguchi S
    J Am Geriatr Soc; 2015 May; 63(5):869-76. PubMed ID: 25912671
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Association Between Postoperative Delirium and Long-term Cognitive Function After Major Nonemergent Surgery.
    Austin CA; O'Gorman T; Stern E; Emmett D; Stürmer T; Carson S; Busby-Whitehead J
    JAMA Surg; 2019 Apr; 154(4):328-334. PubMed ID: 30649138
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Antidepressant, anxiolytic and procognitive effects of rivastigmine and donepezil in the chronic mild stress model in rats.
    Papp M; Gruca P; Lason-Tyburkiewicz M; Willner P
    Psychopharmacology (Berl); 2016 Apr; 233(7):1235-43. PubMed ID: 26769042
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Cholinesterase inhibitor treatment in patients with delirium.
    Berg RM; Möller K
    Lancet; 2011 Mar; 377(9769):900; author reply 901. PubMed ID: 21397758
    [No Abstract]   [Full Text] [Related]  

  • 92. Cerebral White Matter Changes on Therapeutic Response to Rivastigmine in Alzheimer's Disease.
    Ho BL; Kao YH; Chou MC; Yang YH
    J Alzheimers Dis; 2016 Aug; 54(1):351-7. PubMed ID: 27567838
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Anaesthetic depth and delirium after major surgery: a randomised clinical trial.
    Evered LA; Chan MTV; Han R; Chu MHM; Cheng BP; Scott DA; Pryor KO; Sessler DI; Veselis R; Frampton C; Sumner M; Ayeni A; Myles PS; Campbell D; Leslie K; Short TG
    Br J Anaesth; 2021 Nov; 127(5):704-712. PubMed ID: 34465469
    [TBL] [Abstract][Full Text] [Related]  

  • 94. A randomized controlled trial of rivastigmine for chronic sequels of traumatic brain injury-what it showed and taught?
    Tenovuo O; Alin J; Helenius H
    Brain Inj; 2009 Jun; 23(6):548-58. PubMed ID: 19484628
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
    Grace J; Daniel S; Stevens T; Shankar KK; Walker Z; Byrne EJ; Butler S; Wilkinson D; Woolford J; Waite J; McKeith IG
    Int Psychogeriatr; 2001 Jun; 13(2):199-205. PubMed ID: 11495394
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Efficacy and safety of rivastigmine in patients with Alzheimer's disease who failed to benefit from treatment with donepezil.
    Auriacombe S; Pere JJ; Loria-Kanza Y; Vellas B
    Curr Med Res Opin; 2002; 18(3):129-38. PubMed ID: 12094822
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Effect of Rivastigmine Augmentation in Treatment of Male Patients With Combat-Related Chronic Posttraumatic Stress Disorder: A Randomized Controlled Trial.
    Rezaei Ardani A; Hosseini G; Fayyazi Bordbar MR; Talaei A; Mostafavi Toroghi H
    J Clin Psychopharmacol; 2017 Feb; 37(1):54-60. PubMed ID: 27930500
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Neurophysiologic predictors of individual risk for post-operative delirium after elective surgery.
    Ross JM; Santarnecchi E; Lian SJ; Fong TG; Touroutoglou A; Cavallari M; Travison TG; Marcantonio ER; Libermann TA; Schmitt EM; Inouye SK; Shafi MM; Pascual-Leone A;
    J Am Geriatr Soc; 2023 Jan; 71(1):235-244. PubMed ID: 36226896
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Diphenhydramine-Induced Antimuscarinic Delirium Treated with Physostigmine and Transdermal Rivastigmine.
    Whitledge JD; Watson CJ; Simpson M; Bakkar A; Boussi L; Scott M; Boyle KL
    J Med Toxicol; 2023 Apr; 19(2):219-223. PubMed ID: 36575250
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluating the Effects of Rivastigmine on Decision-Making in Patients with Mild Cognitive Impairment by Cambridge Neuropsychological Test Automated Battery (CANTAB); A Randomized, Double-Blind, Placebo-Controlled Trial.
    Sadeghi S; Mohammadian F; Tehrani-Doost M; Gholami K; Mohebbi N
    Iran J Pharm Res; 2023; 22(1):e138943. PubMed ID: 38444714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.